MSR1 and neoplasm: For these experiments DCs were isolated from established tumors and incubated with Mam-A2.4 splenocytes, Mam-A2.4 specific peptide and tumor-explant supernatants along with 0, 10, 25 or 50 μg/ml of anti-Msr1.